======= ACAA1 ======= == Gene Information == * **Official Symbol**: ACAA1 * **Official Name**: acetyl-CoA acyltransferase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=30|30]] * **UniProt**: [[https://www.uniprot.org/uniprot/P09110|P09110]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ACAA1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ACAA1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604054|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes an enzyme operative in the beta-oxidation system of the peroxisomes. Deficiency of this enzyme leads to pseudo-Zellweger syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: N/A |Thiolase N| |Thiolase C| |acetate CoA-transferase activity| |auxin catabolic process| |phenylacetate catabolic process| |auxin metabolic process| |palmitoyl-CoA oxidase activity| |toxin catabolic process| |acetyl-CoA C-acyltransferase activity| |xenobiotic catabolic process| |alpha-linolenic acid metabolic process| |fatty acid beta-oxidation using acyl-CoA oxidase| |hormone catabolic process| |toxin metabolic process| |benzene-containing compound metabolic process| |very long-chain fatty acid metabolic process| |bile acid metabolic process| |peroxisomal matrix| |secondary metabolic process| |fatty acid beta-oxidation| |specific granule lumen| |protein localization to peroxisome| |protein targeting to peroxisome| |establishment of protein localization to peroxisome| |peroxisomal transport| |fatty acid oxidation| |lipid oxidation| |peroxisome organization| |fatty acid catabolic process| |unsaturated fatty acid metabolic process| |peroxisome| |long-chain fatty acid metabolic process| |monocarboxylic acid catabolic process| |detoxification| |xenobiotic metabolic process| |cellular response to xenobiotic stimulus| |cellular lipid catabolic process| |lipid modification| |hormone metabolic process| |steroid metabolic process| |carboxylic acid catabolic process| |organic acid catabolic process| |lipid catabolic process| |response to xenobiotic stimulus| |fatty acid metabolic process| |protein targeting| |establishment of protein localization to organelle| |small molecule catabolic process| |aromatic compound catabolic process| |organic hydroxy compound metabolic process| |organic cyclic compound catabolic process| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |drug metabolic process| |neutrophil activation| |granulocyte activation| |response to toxic substance| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |monocarboxylic acid metabolic process| |regulation of hormone levels| |myeloid leukocyte activation| |leukocyte activation involved in immune response| |cell activation involved in immune response| |intracellular membrane-bounded organelle| |regulated exocytosis| |protein localization to organelle| |leukocyte mediated immunity| |exocytosis| |carboxylic acid metabolic process| |leukocyte activation| |cellular lipid metabolic process| |oxidation-reduction process| |intracellular protein transport| |oxoacid metabolic process| |secretion by cell| |organic acid metabolic process| |export from cell| |cell activation| |immune effector process| |secretion| |lipid metabolic process| |protein transport| |intracellular transport| |peptide transport| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| |establishment of localization in cell| |nitrogen compound transport| |immune response| |extracellular region| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp234|Ethanol 0.01 R05 exp234]]|1.72| |[[:results:exp246|UM0011500 10μM R05 exp246]]|1.76| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|1.79| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|1.94| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|2.32| ^Gene^Correlation^ |[[:human genes:a:acsl3|ACSL3]]|0.407| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13118 * **Expression level (log2 read counts)**: 5.34 {{:chemogenomics:nalm6 dist.png?nolink |}}